NIH-funded research R01 grant

Understanding brain sugar patterns to support memory and healing

Official title: Chemical approaches to understanding chondroitin sulfate glycosaminoglycans and their roles in brain plasticity and pathology

Funded at California Institute of Technology · NIH-11330615 · Data updated 2026-11-12

A research project aims to uncover how brain sugar molecules called chondroitin sulfate glycosaminoglycans influence brain plasticity, memory, and repair, with potential implications for Alzheimer’s disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCalifornia Institute of Technology
NIH-funded
Lab location1 site (Pasadena, United States)
Project startJune 15, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$644,471
NIH project number5R01AG087519-11
Project IDNIH-11330615 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with Alzheimer’s disease dementia or related cognitive syndromes who may be eligible for future translational studies or who could contribute samples or data.

Less likely to help

Healthy individuals or those without Alzheimer’s-related conditions may not directly benefit from this basic-chemistry study.

What this research studies

This project uses chemistry and brain biology to study how specific sulfation patterns on chondroitin sulfate molecules affect brain function. Researchers will create and test new chemical tools to observe and manipulate these sugars in the brain, focusing on how they relate to plasticity, memory, and repair after injury. By identifying which sulfation motifs matter, the work hopes to reveal targets for reducing inflammation and promoting neuronal healing in conditions like Alzheimer’s disease. The team has already developed models lacking certain motifs in the brain and will build on these findings to explore functions of the CS A and CS E motifs. The goal is to connect molecular structure to brain behavior and to create methods that could someday support therapies for cognitive decline.

Why it matters

Potential benefit: If successful, the work could lead to new approaches to modulate brain plasticity and inflammation, potentially informing future therapies for neurodegenerative diseases like Alzheimer’s.

How similar studies have gone: Prior work showed that specific sulfation patterns affect brain networks and memory in animal models, suggesting a promising foundation for this approach.

Where this research is happening

  • California Institute of Technology
    Pasadena, United States
    Active

Researchers

  • Principal investigator: Hsieh-Wilson, Linda C — California Institute of Technology
  • Study coordinator: Hsieh-Wilson, Linda C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.